These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6980966)

  • 1. Lymphocyte abnormality associated with HLA-B8 in healthy young adults.
    McCombs CC; Michalski JP
    J Exp Med; 1982 Sep; 156(3):936-41. PubMed ID: 6980966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
    Amer A; Singh G; Darke C; Dolby AE
    Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.
    Hashimoto S; McCombs CC; Michalski JP
    Clin Exp Immunol; 1989 Jun; 76(3):317-23. PubMed ID: 2787712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B8/DR3 phenotype and the primary immune response.
    Kallenberg CG; Klaassen RJ; Beelen JM; The TH
    Clin Immunol Immunopathol; 1985 Jan; 34(1):135-40. PubMed ID: 3871182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B8, DR3 antigens and production of human leucocyte migration inhibitory factor (LIF) by mononuclear cells stimulated with concanavalin A (Con A).
    Caruso C; Bellina L
    Tissue Antigens; 1983 Aug; 22(2):167-9. PubMed ID: 6353661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.
    Hall RP; Leiserson WM; Chused TM; Lawley TJ
    J Invest Dermatol; 1984 Mar; 82(3):231-4. PubMed ID: 6230405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive effect of Fusarium mycotoxin as a function of HLA antigens.
    Berek L; Petri IB; Mesterházy A; Téren J
    Acta Microbiol Immunol Hung; 2002; 49(1):99-104. PubMed ID: 12073830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates.
    McCombs CC; Michalski JP; deShazo R; Bozelka B; Lane JT
    Clin Immunol Immunopathol; 1986 Apr; 39(1):112-20. PubMed ID: 3485020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
    Modica MA; Cammarata G; Caruso C
    J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.
    Candore G; Colucci AT; Modica MA; Caruso C
    Immunopharmacol Immunotoxicol; 1991; 13(4):551-61. PubMed ID: 1774436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte activation by a gluten fraction, glyc-gli. Studies of adult coeliac patients and healthy controls.
    Scott H; Fausa O; Thorsby E
    Scand J Immunol; 1983 Sep; 18(3):185-91. PubMed ID: 6604938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
    Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
    Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1.
    Hashimoto S; Michalski JP; Berman MA; McCombs C
    Clin Exp Immunol; 1990 Feb; 79(2):227-32. PubMed ID: 2311300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
    Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
    Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals.
    Modica MA; Zambito AM; Candore G; Caruso C
    Immunobiology; 1990 Nov; 181(4-5):257-66. PubMed ID: 2129202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HL-A antigen in Sjögren's syndrome.
    Nahir AM; Scharf Y; Gidoni O; Koren L; Zonis S; Barzilai A
    Ann Ophthalmol; 1980 Sep; 12(9):1084-6. PubMed ID: 6985419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
    Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
    Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
    Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
    J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.